Tackle Trustee Hugh Gunn was interviewed on ITV this week about a new Diagnostic Blood Test which costs less than £50 and can predict whether patients with advanced prostate cancer are likely to respond to certain drugs and whether they might be better served by alternative therapy.
The blood test identified a particular gene which is resistant to the drug. This test could save the NHS thousands of pounds.
Watch Hugh’s interview here.